Skip to main content
UniHealth

Doctor search

Elham Jafroodi, NP

Nurse Practitioner · Stanford

NPI 1033473533

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Elham Jafroodi’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$48,892

Medicare paid this office $48,892 for 242 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)167$37,664$119
Return visit (30+ min)76$7,199$73
Short return visit (20+ min)38$2,082$45

Who their Medicare patients are

242 Original Medicare patients in 2024. Average age 76 · Women 62% · Also on Medicaid 19% · Health risk score 2.26. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Cancer 60% · Coronary heart disease 30% · Chronic kidney disease 30% · Diabetes 29% · Atrial fibrillation 24% · Heart failure 21% · Depression 17% · COPD 10% · Dementia 8% · Stroke 7%.

The office billed $171,313, Medicare allowed $63,595 and paid $48,892; for 488 services of 7 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024242488762.26$171,313$48,892
2023239612762.04$175,207$51,705
2022163328762.24$93,606$22,659
2021205418752.08$117,815$23,209
2020249447742.21$91,174$22,363
2019237371752.63$197,525$21,516
2018227437742.74$296,837$23,776
2017231462742.86$192,826$23,501
2016114175752.56$55,677$9,221
201591116742.41$33,592$6,505
20144862751.98$11,691$3,501
20136287761.93$14,121$3,029

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Long return visit (40+ min)140$27,642$109
Return visit (30+ min)139$19,492$74
Telephone medical discussion with physician, 21-30 minutes20$1,560$74
Short return visit (20+ min)21$1,193$52
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or15$912$25

2022: 4 services

Original Medicare services billed in 2022
Long return visit (40+ min)58$9,234$113
Short return visit (20+ min)103$8,514$47
Return visit (30+ min)32$2,856$73
Telephone medical discussion with physician, 21-30 minutes18$1,458$77

2021: 2 services

Original Medicare services billed in 2021
Short return visit (20+ min)161$16,402$50
Return visit (30+ min)72$5,510$71

2020: 3 services

Original Medicare services billed in 2020
Return visit (30+ min)183$14,937$54
Short return visit (20+ min)103$6,293$41
Long return visit (40+ min)11$1,051$88

2019: 3 services

Original Medicare services billed in 2019
Return visit (30+ min)206$19,171$58
Long return visit (40+ min)18$1,459$77
Short return visit (20+ min)18$632$35

2018: 3 services

Original Medicare services billed in 2018
Return visit (30+ min)182$19,480$57
Short return visit (20+ min)63$2,579$36
Long return visit (40+ min)19$1,485$78

2017: 3 services

Original Medicare services billed in 2017
Return visit (30+ min)178$18,234$58
Short return visit (20+ min)78$3,646$38
Short return visit33$676$18

2016: 3 services

Original Medicare services billed in 2016
Return visit (30+ min)72$5,712$59
Short return visit (20+ min)43$1,905$38
Long return visit (40+ min)16$1,279$75

2015: 3 services

Original Medicare services billed in 2015
Return visit (30+ min)52$3,158$54
Long return visit (40+ min)22$2,369$85
Short return visit (20+ min)14$543$39

2014: 1 service

Original Medicare services billed in 2014
Return visit (30+ min)47$3,482$57

2013: 2 services

Original Medicare services billed in 2013
Return visit (30+ min)41$1,643$34
Short return visit (20+ min)30$1,288$35

Drugs they prescribed that Part D paid

$1,576,227

Pharmacies billed $1,576,227 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

558 generic and fewer than 11 brand-name prescriptions · $1,576,227 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Jakafi24$364,516$15,188
Calquence12$184,841$15,403
Ibrance12$169,618$14,135
Eliquis41$28,567$697
Xarelto16$23,937$1,496
See all 17 drugs
Every Part D drug this clinician prescribed
Jakafi24$364,516$15,188
Calquence12$184,841$15,403
Ibrance12$169,618$14,135
Eliquis41$28,567$697
Xarelto16$23,937$1,496
Exemestane34$4,831$142
Letrozole161$4,652$29
Anastrozole84$1,676$20
Abiraterone Acetate12$1,569$131
Ondansetron21$1,009$48
Tamoxifen Citrate28$704$25
Hydroxyurea16$349$22
Diphenoxylate-Atropine13$171$13
Prochlorperazine Maleate22$167$8
Acyclovir16$134$8
Prednisone15$113$8
Loperamide11$73$7

Year by year

Part D prescribing by year
2024741241NoneNone$1,576,227
2023918267None22%$1,545,566
2022690215None25%$1,527,609
20217362392% (11)None$1,431,065
20209182963% (23)26%$1,724,828
20194222063% (14)20%$497,042
2018135739% (12)16%$5,875
20171286614% (18)None$3,377
201674380% (0)None$1,378
2015247647% (18)17%$249,253
20142716510% (26)11%$228,465
201312238None18%$46,619

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 21 drugs

Part D drugs prescribed in 2023
Jakafi20$355,591$17,780
Eliquis52$40,735$783
Xarelto27$32,165$1,191
Exemestane39$14,675$376
Letrozole127$7,625$60
Anastrozole95$2,500$26
Entecavir12$1,010$84
Hydroxyurea22$897$41
Tamoxifen Citrate18$715$40
Ondansetron42$563$13
Diphenoxylate-Atropine16$486$30
Dexamethasone16$385$24
Levothyroxine15$355$24
Lidocaine-Prilocaine14$285$20
Potassium Chloride13$278$21
Loperamide21$233$11
Acyclovir19$208$11
Allopurinol19$180$9
Prochlorperazine Maleate13$114$9
Prednisone12$78$6
Hydrocortisone11$63$6

2022: 17 drugs

Part D drugs prescribed in 2022
Jakafi23$343,689$14,943
Xtandi22$305,244$13,875
Verzenio12$176,565$14,714
Eliquis34$37,557$1,105
Xarelto23$27,347$1,189
Exemestane19$8,050$424
Letrozole101$4,722$47
Anastrozole75$1,929$26
Acyclovir18$561$31
Tamoxifen Citrate22$497$23
Allopurinol33$370$11
Ondansetron27$305$11
Prochlorperazine Maleate23$243$11
Lidocaine-Prilocaine11$204$19
Loperamide13$133$10
Dexamethasone20$125$6
Prednisone15$61$4

2021: 19 drugs

Part D drugs prescribed in 2021
Jakafi29$354,540$12,226
Xtandi26$348,037$13,386
Tagrisso11$179,004$16,273
Xarelto33$27,434$831
Eliquis30$24,079$803
Exemestane16$7,426$464
Letrozole139$5,112$37
Anastrozole61$2,065$34
Hydroxyurea13$771$59
Acyclovir16$705$44
Ondansetron27$530$20
Tamoxifen Citrate25$351$14
Dexamethasone24$340$14
Warfarin13$332$26
Allopurinol24$327$14
Venlafaxine Hcl Er14$325$23
Ondansetron Odt12$262$22
Prochlorperazine Maleate19$247$13
Pantoprazole11$123$11

2020: 24 drugs

Part D drugs prescribed in 2020
Jakafi42$505,755$12,042
Xtandi19$239,262$12,593
Venclexta13$90,841$6,988
Eliquis29$18,741$646
Exemestane40$10,700$267
Imatinib Mesylate12$4,838$403
Letrozole99$4,452$45
Anastrozole83$2,478$30
Tamoxifen Citrate53$1,306$25
Hydroxyurea22$1,268$58
Acyclovir18$877$49
Potassium Chloride19$857$45
Allopurinol42$754$18
Ondansetron27$372$14
Gabapentin23$368$16
Dexamethasone20$293$15
Prochlorperazine Maleate20$244$12
Lidocaine-Prilocaine15$233$16
Ondansetron Odt13$220$17
Oxycodone11$214$19
Warfarin14$203$14
Prednisone20$176$9
Alendronate11$134$12
Lorazepam11$39$4

2019: 11 drugs

Part D drugs prescribed in 2019
Jakafi16$165,919$10,370
Exemestane13$2,646$204
Hydroxyurea21$1,366$65
Anastrozole51$1,322$26
Tamoxifen Citrate26$1,152$44
Letrozole14$661$47
Allopurinol25$486$19
Dexamethasone17$380$22
Ondansetron21$113$5
Prochlorperazine Maleate12$82$7
Prednisone12$66$6

2018: 1 drug

Part D drugs prescribed in 2018
Nystatin14$396$28

2017: 2 drugs

Part D drugs prescribed in 2017
Clotrimazole19$479$25
Gabapentin12$97$8

2016: 1 drug

Part D drugs prescribed in 2016
Ondansetron12$130$11

2015: 4 drugs

Part D drugs prescribed in 2015
Xtandi11$98,293$8,936
Bicalutamide25$860$34
Ondansetron37$359$10
Prednisone18$142$8

2014: 9 drugs

Part D drugs prescribed in 2014
Afinitor11$203,488$18,499
Bicalutamide23$700$30
Ondansetron33$484$15
Prednisone30$262$9
Levothyroxine12$141$12
Gabapentin11$118$11
Alendronate11$100$9
Prochlorperazine Maleate15$90$6
Amlodipine Besylate14$68$5

2013: 4 drugs

Part D drugs prescribed in 2013
Bicalutamide12$530$44
Megestrol Acetate14$383$27
Levothyroxine15$114$8
Prednisone19$88$5

Money from drug and device companies

$674 in 2025

Industry payments by year
2025611None$674
2024715$1,155$1,829
2023534$6,125$9,022
202218None$136
2021310$750$1,059

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPEnhertu$176
4 payments
  • Meals for Enhertu · 2025-10-17 · $17
  • Meals for Enhertu · 2025-10-15 · $6
  • Meals · 2025-05-16 · $30
  • Meals · 2025-04-29 · $124
Edwards LifesciencesSapien 3 Ultra Resilia$137
1 payment
  • Meals for Sapien 3 Ultra Resilia · 2025-03-28 · $137
Sumitomo Pharma AmericaOrgovyx$119
2 payments
  • Meals for Orgovyx · 2025-11-22 · $94
  • Meals for Orgovyx · 2025-01-10 · $25
Argenx USVyvgart$115
1 payment
  • Meals for Vyvgart · 2025-11-11 · $115
AmgenKrystexxa$85
1 payment
  • Meals for Krystexxa · 2025-07-08 · $85
Daiichi SankyoEnhertu$43
2 payments
  • Meals for Enhertu · 2025-10-16 · $18
  • Meals for Enhertu · 2025-09-23 · $24
See all 11 published payments
Every published payment
Sumitomo Pharma AmericaMeals · 2025-11-22Orgovyx$94
Argenx USMeals · 2025-11-11Vyvgart$115
AstraZeneca Pharmaceuticals LPMeals · 2025-10-17Enhertu$17
Daiichi SankyoMeals · 2025-10-16Enhertu$18
AstraZeneca Pharmaceuticals LPMeals · 2025-10-15Enhertu$6
Daiichi SankyoMeals · 2025-09-23Enhertu$24
AmgenMeals · 2025-07-08Krystexxa$85
AstraZeneca Pharmaceuticals LPMeals · 2025-05-16None$30
AstraZeneca Pharmaceuticals LPMeals · 2025-04-29None$124
Edwards LifesciencesMeals · 2025-03-28Sapien 3 Ultra Resilia$137
Sumitomo Pharma AmericaMeals · 2025-01-10Orgovyx$25
See earlier years (2024, 2023, 2022, 2021)

2024: $1,829

Payments by company in 2024
Mirati TherapeuticsKrazati$1,115
7 payments
  • Meals for Krazati · 2024-05-06 · $16
  • Meals for Krazati · 2024-04-15 · $7
  • Meals for Krazati · 2024-04-15 · $19
  • Meals for Krazati · 2024-02-01 · $23
  • Travel for Krazati · 2024-01-18 · $74
  • Honoraria for Krazati · 2024-01-18 · $875
  • Meals for Krazati · 2024-01-18 · $102
AstraZeneca Pharmaceuticals LPLynparza$280
1 payment
  • Consulting for Lynparza · 2024-08-26 · $280
Mayne Pharma CommercialAnnovera$122
1 payment
  • Meals for Annovera · 2024-11-12 · $122
Sage TherapeuticsNone$107
1 payment
  • Meals · 2024-01-09 · $107
Hologic Sales and ServiceAptima$105
1 payment
  • Meals for Aptima · 2024-05-14 · $105
Sumitomo Pharma AmericaOrgovyx$83
3 payments
  • Meals for Orgovyx · 2024-11-25 · $28
  • Meals for Orgovyx · 2024-09-19 · $31
  • Meals for Orgovyx · 2024-08-28 · $23
PfizerInlyta$18
1 payment
  • Education for Inlyta · 2024-09-19 · $18

2023: $9,022

Payments by company in 2023
Mirati TherapeuticsKrazati$8,755
30 payments
  • Meals for Krazati · 2023-12-21 · $25
  • Travel for Krazati · 2023-12-19 · $155
  • Meals for Krazati · 2023-12-19 · $10
  • Meals for Krazati · 2023-12-19 · $24
  • Meals for Krazati · 2023-12-19 · $112
  • Meals for Krazati · 2023-12-19 · $69
  • Meals for Krazati · 2023-12-19 · $88
  • Meals for Krazati · 2023-12-19 · $44
  • Paid to speak or teach for Krazati · 2023-11-21 · $1,531
  • Paid to speak or teach for Krazati · 2023-11-17 · $1,881
  • Meals for Krazati · 2023-11-16 · $81
  • Travel for Krazati · 2023-11-14 · $120
  • Travel for Krazati · 2023-11-14 · $208
  • Travel for Krazati · 2023-11-09 · $952
  • Meals for Krazati · 2023-11-01 · $110
  • Paid to speak or teach for Krazati · 2023-10-27 · $744
  • Meals for Krazati · 2023-10-11 · $23
  • Travel for Krazati · 2023-10-10 · $356
  • Paid to speak or teach for Krazati · 2023-10-10 · $1,356
  • Meals for Krazati · 2023-09-28 · $36
  • Meals for Krazati · 2023-08-31 · $26
  • Paid to speak or teach for Krazati · 2023-08-18 · $613
  • Meals for Krazati · 2023-06-30 · $21
  • Meals for Krazati · 2023-05-15 · $16
  • Meals for Krazati · 2023-05-02 · $21
  • Meals for Krazati · 2023-03-29 · $86
  • Meals for Krazati · 2023-03-09 · $20
  • Meals for Krazati · 2023-03-09 · $9
  • Meals for Krazati · 2023-01-11 · $3
  • Meals for Krazati · 2023-01-11 · $17
Mayne Pharma CommercialNextstellis$124
1 payment
  • Meals for Nextstellis · 2023-07-11 · $124
BiogenNone$94
1 payment
  • Meals · 2023-03-14 · $94
Sumitomo Pharma AmericaOrgovyx$29
1 payment
  • Meals for Orgovyx · 2023-12-13 · $29
GlaxoSmithKlineOjjaara$19
1 payment
  • Meals for Ojjaara · 2023-10-18 · $19

2022: $136

Payments by company in 2022
EpizymeTazverik$136
8 payments
  • Meals for Tazverik · 2022-07-18 · $24
  • Meals for Tazverik · 2022-06-22 · $21
  • Meals for Tazverik · 2022-05-05 · $3
  • Meals for Tazverik · 2022-05-05 · $26
  • Meals for Tazverik · 2022-04-21 · $20
  • Meals for Tazverik · 2022-03-04 · $24
  • Meals for Tazverik · 2022-03-04 · $4
  • Meals for Tazverik · 2022-02-09 · $13

2021: $1,059

Payments by company in 2021
GenentechTecentriq$750
1 payment
  • Consulting for Tecentriq · 2021-11-10 · $750
EpizymeTazverik$262
8 payments
  • Meals for Tazverik · 2021-12-20 · $28
  • Meals for Tazverik · 2021-11-23 · $25
  • Meals for Tazverik · 2021-10-15 · $31
  • Meals for Tazverik · 2021-08-31 · $15
  • Meals for Tazverik · 2021-07-09 · $23
  • Meals for Tazverik · 2021-05-24 · $20
  • Education for Tazverik · 2021-05-20 · $99
  • Meals for Tazverik · 2021-02-16 · $21
Biohaven PharmaceuticalsNurtec Odt$47
1 payment
  • Meals for Nurtec Odt · 2021-03-25 · $47

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1033473533
Licence
CA 21741
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2012-06-28
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.